Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.45%, DAX +0.32%, CAC40 +0.17%

Feb 20 ,2026

  • Synopsis

    • European indices are set to open higher. Tension with Iran continue to escalate, with reports indicating US military prepared to strike the country as soon as this weekend

    • Asia equities trading mixed Friday. Japan's two main benchmarks gapped lower at the bell and stayed near their trough all day. Hang Seng reopened with sharp falls with rotation out of 'traditional internet' names and into AI pure plays evident

    • US equities finished mostly lower in Thursday trading, though ended off worst levels. S&P broke a three-session string of gains (though remains higher WTD). Big tech was mostly weaker with AAPL the notable decliner

    • Friday sees, in central banks, ECB's Lagarde acceptance speech at 1:00CET for the Wolfgang Friedmann Memorial Award at Columbia Law School. In Latvia, there's expert panel event at 9:00CET providing an insight into the dynamics of public debt among European countries and in Italy, there's 32nd ASSIOM FOREX Congress (through Sat), with Bank of Italy's Panetta due to speak at 11:30CET on Sat.

    • Economic: Eurozone, France, Germany, UK Feb flash manufacturing/services PMIs, Germany Jan PPI, UK Jan retail sales, public sector net borrowing, Denmark Q4 preliminary GDP, Sweden Jan final CPI

    • Earnings reported so far today: (UNI.IM) Unipol Gruppo reports FY net income €1.53B vs FactSet €1.42B.. (AI.FP) Air Liquide reports FY EPS €6.10 vs consensus €6.01 (ALK.B.DC) ALK-Abello reports FY EBIT DKK1.65B vs FactSet DKK1.61B. (CANTA.SS) Cantargia reports FY EPS SEK0.59 vs FactSet SEK0.44. (SFZN.SW) Siegfried Holding reports FY core net income CHF162.1M vs FactSet CHF162.3M

  • Politics/Macro/World News

    • Trump warns Iran of 'bad things' if no deal made, sets deadline of 10-15 days (Reuters )

    • Blue Owl's Woes Expose Private Credit Risks for Retail Investors (Bloomberg )

  • Top company news

    • Earnings/updates

      • MONC.IM (Moncler) -- reports FY net income €626.7M vs FactSet €596.2M [23 est, €574-630.0M]

      • SIKA.SW (Sika Group) -- reports FY EPS CHF6.50 vs FactSet CHF6.92 [20 est, CHF6.34-8.67]

      • SFZN.SW (Siegfried Holding) -- reports FY core net income CHF162.1M vs FactSet CHF162.3M [8 est, CHF149.3-174M]

      • LI.FP (Klepierre) -- reports FY CFPS €2.72 vs FactSet €2.69

      • GTT.FP (Gaztransport & Technigaz) -- reports FY net income €413.6M vs FactSet €425.6M [11 est, €393.7-475M]

      • MMB.FP (Lagardere) -- reports FY adjusted net income €319M vs FactSet €261M

      • NK.FP (Imerys) -- reports FY current EPS €1.73 vs FactSet €1.76 [6 est, €1.53-1.89]

      • MOL.HB (MOL Hungarian Oil & Gas) -- reports Q4 EPS Ft121.3 vs FactSet Ft124.03 [2 est, Ft97.03-151.03]

      • CANTA.SS (Cantargia) -- reports FY EPS SEK0.59 vs FactSet SEK0.44 [1 est]

      • COFA.FP (Coface) -- reports FY net income €222.0M vs FactSet €231.6M [5 est, €220-254.6M]

      • COFA.FP (Coface) -- Follow-up: Coface reports FY results

      • BION.SW (BB Biotech) -- BB Biotech reports final Q4 earnings inline with preliminary release: Launch of a new share buyback program

      • ALHG.FP (Louis Hachette Group SA) -- reports FY adjusted net income €212M, +23% vs year-ago €173M

      • ALLN.SW (Allreal Holding) -- reports FY net income (ex-revaluation gains) CHF122.1M vs FactSet CHF120.9M; Positive outlook for 2026

    • M&A

      • GLEN.LN (Glencore) -- launched talks for stake sale in Kazzinc Ltd in Kazakhstan -- Bloomberg, citing people familiar with the matter

      • STAN.LN (Standard Chartered) -- launches process to sell Botswana business - Bloomberg

      • VISTAA.MM (Vista Oil & Gas) -- provides update related to acquisition of Equinor's assets in Vaca Muerta

      • QBE.AU (QBE Insurance Group) -- Swiss Re Corporate Solutions to acquire QBE's Global Trade Credit and Surety business; terms undisclosed

      • AGGK.LN (Aggreko) -- Aggreko's owners moving forward with plans for either US IPO or stake sale, targeting $12B valuation - FT

      • DOFG.NO (DOF Group) -- announces high-grading of AHTS fleet through vessel transactions

      • 500672.IN (Novartis India) -- Novartis to sell 70.7% stake in Novartis India to consortium

    • Healthcare

      • ROG.SW (Roche Holding) -- Roche's giredestrant gets FDA NDA acceptance in ESR1-mutated, ER-positive advanced breast cancer

      • 4519.JP (Chugai Pharmaceutical) -- launches ELEVIDYS Intravenous Infusion as a regenerative medical product for the treatment of Duchenne muscular dystrophy (DMD) in Japan

      • PRTC.LN (PureTech Health) -- issues press release on previously disclosed FDA and EC orphan drug designations to deupirfenidone (LYT-100) for the treatment of idiopathic pulmonary fibrosis (IPF)

      • RHC.AU (Ramsay Health Care) -- presents proposal to distribute Ramsay Santé shares held by Ramsay to Ramsay shareholders

    • Other

      • DGE.LN (Diageo) -- CEO Dave Lewis planning major overhaul of executive team - FT

      • ORA.FP (Orange) -- Transcript Intelligence: Orange Capital Markets Day

      • UCG.IM (UniCredit) -- cancels 53.7M treasury shares

      • RECSI.NO (REC Silicon) -- shareholders to vote on 12-Mar on previously disclosed rights issue, share capital reduction by reduction of the nominal value

      • RECSI.NO (REC Silicon) -- announces key information relating to previously disclosed rights issue

      • PRS.NO (Prosafe) -- appointa Halvdan Kielland as permanent CFO

      • AKAST.NO (Akastor) -- Akastor's 66.7% owned affiliate AKOFS Offshore secures contract worth ~$213M for its vessel "Aker Wayfarer"

      • Quick Take: Rio Tinto (3.7%) on broadly in-line FY result with NPAT miss vs SA; cash generation strained amid heavy investment phase

      • Ramsay Health Care presents proposal to distribute Ramsay Santé shares held by Ramsay to Ramsay shareholders

  • Key rating changes

    • Upgrades

      • CAST.SS (Castellum AB) -- to buy from hold at ABG Sundal Collier

      • OEM.B.SS (OEM International) -- to buy from hold at Handelsbanken

      • STJ.LN (St. James's Place) -- to buy from neutral at UBS

      • SUS.SS (Surgical Science Sweden) -- to buy from hold at Pareto

      • TEMN.SW (Temenos) -- to neutral from underperform at Oddo

      • TKA.GR (ThyssenKrupp) -- to buy from hold at Jefferies

      • CINT.SS (Cint Group) upgraded to buy from hold at SEB

    • Downgrades

      • TIT.IM (Telecom Italia) -- to hold from buy at Deutsche Bank

      • ARCAD.NA (ARCADIS) -- to sector weight from overweight at KeyBanc

      • BITTI.FH (Bittium downgraded to reduce from accumulate at Inderes

    • Initiations

      • AZN.SS (AstraZeneca) -- buy at Sparebank 1 Markets

      • BOOZT.SS (Boozt Fashion) initiated buy at Nordea

    • Other Actions

      • CBK.GR (Commerzbank) -- transferred equal weight at Barclays; prior rating was equal weight

  • Data

    • Nikkei (1.04%) to 56871.04

    • Hang Seng (0.63%) to 26538.83

    • Shanghai Composite +0.00% to 4082.07

    • S&P futures +20.8 vs prior close of 6877.0

    • €-$ (0.0021) or (0.18%) to 1.1755

    • $-¥ +0.23 or +0.15% to 155.22

    • €-¥ (0.05) or (0.03%) to 182.45

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE